Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales

Stryker, a leading provider of orthopedic devices, reported growth in sales of key products as it benefited from installations of its Mako robot.

Speaking on Stryker’s conference call to discuss the results, Robert Marcus, an analyst at J.P. Morgan, said he was “kind of blown away by how good the growth rates were in hip, knee and extremity” in the first quarter. Stryker CEO Kevin Lobo attributed the “pretty breathtaking” knee growth outside the U.S. (OUS) to a mix of an easy comparison to the omicron-affected start of 2022 and other factors.